Our Partners











CHS-Shire Fellowship Program




                  


The Canadian Hemophilia Society - Shire Fellowship was created to engage hemophilia program professionals/graduate students from the disciplines of nursing, physiotherapy, social work and other related allied health disciplines in research focused on improving services and quality of life for people and families whose lives are affected by inherited bleeding disorders.

The fellowship was made possible thanks to generous financial support from Shire.

Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. Shire has best-in-class products available in more than 100 countries across core therapeutic areas including Hematology, Immunology, Neuroscience, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; a growing franchise in Oncology; and an emerging, innovative pipeline in Ophthalmics. Its employees work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.

The CHS was proud to be in a partnership with Shire in order to offer this important fellowship program.

This program offered one or more fellowships not exceeding total funding of $20,000. 

Depending upon the number and quality of applications, funding for different amounts was possible, as was the offering of more than one fellowship, within the allotted total budget stated above.
 
The major portion of the grant was be to cover the research time for the successful candidate(s). A small amount could be devoted to project expenses.

Fellowships were offered for a one-year period starting in April 2017. 

It should be noted that allocation of this grant for future years is conditional to the CHS having received from Shire funding confirmation.